• Campus Header
  • Institute Header
Home
Academics

Integrated first degree

B.E.(Chemical)
B.E.(Civil)
B.E.(Computer Science)
B.E.(Electrical and Electronics)
B.E.(Electronics and Communication)
B.E.(Electronics and Instrumentation)
B.E.(Mechanical)
B.Pharm.(Pharmacy)
M.Sc.(Biological Sciences)
M.Sc.(Chemistry)
M.Sc.(Economics)
M.Sc.(Mathematics)
M.Sc.(Physics)

Higher Degree

M.E.(Biotechnology)
M.E.(Chemical)
M.E.(Civil with specialization in Structural Engineering)
M.E.(Civil with specialization in Transportation Engineering)
M.E.(Communication Engineering)
M.E.(Computer Science)
M.E.(Design Engineering)
M.E.(Embedded Systems)
M.E.(Manufacturing Systems Engineering)
M.E.(Mechanical)
M.E. (Microelectronics)
M.E. (Sanitation Science, Technology and Management)
M.Pharm.(Pharmacology)
M.Pharm.(Pharmaceutics)
M.E.(Mechanical with specialization in Thermal Engineering)
M.E.(Environmental Engineering)

Doctoral Programmes

Biological Sciences
Chemical Engineering
Chemistry
Civil Engineering
Computer Science & Information Systems
Economics & Finance
Electrical & Electronics Engineering
Humanities & Social Sciences
Mathematics
Mechanical Engineering
Pharmacy
Physics
Departments
Research & Innovation
Centers
Students
Admission
DIVISIONS
QUICK LINKS
Campus
Pilani
Dubai
K K Birla Goa
Hyderabad
BITSoM, Mumbai
BITS Law School, Mumbai
Links For
BITS Library
Admissions
Faculty
Practice School
Placements
Student Arena
Career
News
Alumni
Internationalization
Events
MOUs
Current Students
Invest in Leaders
Outreach
Picture Gallery
Admission
Integrated first degree
Higher degree
Doctorol programmes
International Admissions
Online Admissions
BITSAT
IMPORTANT CONTACTS
Pilani
Dubai
Goa
Hyderabad
RESEARCH & INNOVATION
Overview
Sponsored Research Projects
Consultancy Based Projects
Patents
Publications
R&D Centers
DEPARTMENTS
Pilani
Dubai
Goa
Hyderabad
Academics

Integrated First Degree

B.E.(Biotechnology)
B.E.(Chemical)
B.E.(Civil)
B.E.(Computer Science)
B.E.(Electrical and Electronics)
B.E.(Electronics and Communication)
B.E.(Electronics and Instrumentation)
B.E.(Manufacturing Engineering)
B.E.(Mechanical)
B.Pharm.(Pharmacy)
M.Sc.(Biological Sciences)
M.Sc.(Chemistry)
M.Sc.(Economics)
M.Sc.(General Studies)
M.Sc.(Mathematics)
M.Sc.(Physics)
B.E. (Mathematics and Computing)

Higher Degree

MBA (Master of Business Administration in Business Analytics)
MBA (Master of Business Administration)
M.E.(Electrical with specialization in Power Electronics and Drives)
MBA (Master of Business Administration)
M.E. Civil – Water Resource Engineering
M. E. Computer Science with Specialization in Information Security with B.Sc. input
M.E. (Mechanical with specialization in Thermal Engineering)
M.E. Chemical Engineering (with specialization in Petroleum Engineering)
M.E. Electronics & Control
M.E. M.Pharm
M.E.(Biotechnology)
M.E.(Chemical)
M.E.(Civil with specialization in Infrastructure Engineering and Management)
M.E.(Civil with specialization in Structural Engineering)
M.E.(Civil with specialization in Transportation Engineering)
M.E.(Communication Engineering)
M.E.(Computer Science)
M.E.(Design Engineering)
M.E.(Embedded Systems)
M.E.(Manufacturing Systems Engineering)
M.E.(Mechanical)
M.E.(Microelectronics)
M.E.(Sanitation Science, Technology and Management)
M.E.(Software Systems)
M.Pharm.(Pharmaceutical Chemistry)
M.Pharm.(Pharmaceutics)
M.Pharm.(Pharmacology)
M.Pharm.(Pharmacy)
M.Sc. General Studies – Communication and Media Studies Stream
Master in Public Health
MBA(Master of Business Administration In Business Analytics)

Doctoral Programmes

Biological Sciences
Chemical Engineering
Chemistry
Civil Engineering
Computer Science & Information Systems
Economics & Finance
Electrical & Electronics Engineering
Humanities & Social Sciences
Management
Mathematics
Mechanical Engineering
Pharmacy
Physics
General Sciences

WILP

Dubai Campus

Integrated First Degree
Higher Degree
Doctoral Programmes
Explore BITS
About
Legacy
Achievements
Social Responsibility
Sustainability
Divisions
Pilani
K K Birla Goa
Hyderabad
Dubai
follow us
  • linkedin
  • twitter
  • facebook
  • youtube
  • instagram
Feedback

Prof. K V G Chandra Sekhar

hyderabad Chemistry

Professor,
Department of Chemistry

Medicinal and Synthetic Organic Chemistry
Birla Institute of Technology & Science, Pilani
Hyderabad Campus
Jawahar Nagar, Kapra Mandal
Dist. Medchal-500 078
Telangana, India
kvgc@hyderabad.bits-pilani.ac.in
kvgcs@yahoo.com
040-66303527

Journal Articles

  1. Srinuvasu Nakka, Swati, Sai Chaitanya Kosana, Suryansh Sengar, Chandu Ala, Murugesan Sankaranarayanan, Vivek Sharma, Nagaraju Devunuri, Kondapalli Venkata Gowri Chandra Sekhar*, Exploring 4-Morpholinopyrrolo-[2,3-d]-Pyrimidine Derivatives as Novel Anti-Cancer Agents: Design, Synthesis and Biological Studies. Journal of Molecular structure. (In press)
  2. Yogesh Mahadu Khetmalis, Singarapalle Shobha, Adinarayana Nandikolla, Ala Chandu, Sankaranarayanan Murugesan, Muthyala Murali Krishna Kumar and Kondapalli Venkata Gowri Chandra Sekhar*, Design, synthesis, and anti-mycobacterial evaluation of 1,8-naphthyridine-3-carbonitrile analogues. RSC Advances, 2024, 14, 22676.
  3. Solai Murugappan, Pranali Vijaykumar Kuthe, Kondapalli Venkata Gowri Chandra Sekhar and Murugesan Sankaranarayanan, Recent developments in thiochromene chemistry. Organic and Biomolecular Chemistry. DOI: 10.1039/d4ob00690a.
  4. Chandu Ala, Renuka Parshuram Josh, Pragya Gupta, Sangam Giri Goswami, Sivaprakash Ramalingam, Kondapalli Venkata Gowri Chandra Sekhar, Murugesan Sankaranarayanan. A critical review of therapeutic interventions in sickle cell disease: Progress and challenges. Archiv Der Pharmazie, 2024; e2400381.
  5. Nakka, S., Raza, A., Chaitanya, K. S., Bandaru, N. V. M. R., Chandu, A., Murugesan, S., Nagaraju D, Sharma, A K. & Kondapalli Venkata Gowri Chandra Sekhar*. Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents. Chemical Biology & Drug Design, 2024, 103 (3), e14502.
  6. Kumar, B. V. S., Khetmalis, Y. M., Chaitanya, K. S., Chandu, A., Shetye, G., Ma, R.,  Murugesan,, Franzblau, S. G.,   & Kondapalli Venkata Gowri Chandra Sekhar*. Design, synthesis and biological evaluation of novel pyrido-[2,3-d]-pyrimidin-2-amine analogues as antimycobacterial agents. Journal of Molecular Structure, 2024, 1303, 137600.
  7. Yogesh Mahadu Khetmalis, Guruvelli Padma Vijaya Sangeetha,Ala Chandu,Swati,Sankaranarayanan Murugesan,Vivek Sharma,Muthyala Murali Krishna Kumar, Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Biological Evaluation of Novel Oxindole Analogs as Anti-Tubercular Agents. Future Medicinal Chemistry 2023, 15 (5), 1323-1342.
  8. Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Boddupalli Venkata Siva kumar, Ala Chandu, Banoth Karan Kumar, Gauri Shetye, Rui Ma, Sankaranarayanan Murugesan, Scott G. Franzblau, Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis and Biological Evaluation of Phenanthridine Amide and 1,2,3-Triazole Analogues against Mycobacterium tuberculosis. RSC Medicinal Chemistry, 2023, 14, 1549-1561.
  9. Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Guruvelli Padma Vijaya Sangeetha, Ala Chandu, Swati, Muthyala Murali Krishna Kumar, Vivek Sharma, Sankaranarayanan Murugesan, and Kondapalli Venkata Gowri Chandra Sekhar*, Tetrahydroisoquinoline based 5-Nitro-2-furoic acid Derivatives: A Promising New Approach for Anti-Tubercular Agents, New Journal of Chemistry, 2023, 47, 15378-15389.
  10. Yogesh Mahadu Khetmalis, Ashna Fathima, Markus Schweipert, Cécile Debarnot, Naga Venkata Madhusudhan Rao Bandaru, Sankaranarayanan Murugesan, Trinath Jamma, Franz-Josef Meyer-Almes and Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-One-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity, International Journal of Molecular Sciences 2023, 24 (13), 11044.
  11. Abirami, Banoth Karan Kumar, Faheem, Sanchita Dey, Samridhi Johri, Rosa M. Reguera, Rafael Bala˜na-Fouce, Kondapalli Venkata Gowri Chandra Sekhar, Murugesan Sankaranarayanan, Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds, European Journal of Medicinal Chemistry, 2023, 257, 115471.
  12. Savita, Adinarayana Nandikolla, Adarash Kumar Shukla, Kondapalli Venkata Gowri Chandra Sekhar and Anupam Bhattacharya, Visible light sensing of ions by a cynoquinoxaline 1,4-dioxide-based probe and its applications. Dalton Transactions, 2023, 52, 4103.
  13. Yogesh Mahadu Khetmalis, Bakhya Shree, Boddupalli Venkata Siva Kumar, Markus Schweipert, Cécile Debarnot, Fathima Ashna, Murugesan Sankaranarayanan, Jamma Trinath, Vivek Sharma, Franz-Josef Meyer-Almes, Kondapalli Venkata Gowri Chandra Sekhar*, Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy. Journal of Molecular Structure, 2023, 1278, 134952.
  14. Bodupalli Venkata Siva Kumar, Yogesh Mahadu Khetmalis, Adinarayana Nandikolla, Banoth Karan Kumar, Kevin Van Calster, Sankaranarayanan Murugesan, Davie Cappoen, and Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Antimycobacterial Evaluation of Novel Tetrahydroisoquinoline Hydrazide Analogs, Chemistry & Biodiversity 2023, 20, e202200939.
  15. Samridhi Johri, Banoth Karan Kumar, Sanchita Dey, Faheem, Rafael Balana-Fouce, Kondapalli Venkata Gowri Chandra Sekhar*, Selvaraj Kunjiappan, Sankaranarayanan Murugesan, Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor – An in-silico analysis. Journal of Molecular Graphics and Modelling 2023, 119, 108397.
  16. Snehal Rajkumar Jadhav, Banoth Karan Kumar, Renuka Parshuram Joshi, Chougule Kishor Suryakant, Ala Chandu, Mohammed Muzaffar-Ur-Rehman, Yogesh Mahadu Khetmalis, Adinarayana Nandikolla, Sankaranarayan Murugesan and Kondapalli Venkata Gowri Chandra Sekhar*, Retrospective Review of Chromane Analogues as Anti-Protozoal Leads: A Decade's Worth of Evolution. Current Topics in Medicinal Chemistry, 2023, 23 (9), 713-735.
  17. Ravi Kiran Panchakarla, Punna Rao Ravi, Manidhar Syam Kumar Buddha, Sumanth Mullangi, and Kondapalli Venkata Gowri Chandra Sekhar*, In silico toxicity assessment and trace level quantification of two genotoxic impurities in silodosin using capillary gas chromatography, Journal of Analytical Science and Technology, 2023 (https://doi.org/10.1186/s40543-023-00378-1).
  18. Surendar Chitti, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Kevin Van Calster, Boddupalli Venkata Siva Kumar, Banoth Karan Kumar, Sankaranarayanan Murugesan, Davie Cappoen, and Kondapalli Venkata Gowri Chandra Sekhar *, Design, Synthesis and Biological Evaluation of Novel Spiro-[chroman-2,4'-piperidin]-4-one Analogues as Anti-Tubercular Agents. Chemistry & Biodiversity 2022,
  19. Surendar Chitti, Kevin Van Calster, Davie Cappoen, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Paul Cos, Banoth Karan Kumar, Sankaranarayanan Murugesan and Kondapalli Venkata Gowri Chandra Sekhar* Design, synthesis and biological evaluation of benzo-[d]-imidazo-[2,1-b]-thiazole and imidazo-[2,1-b]-thiazole carboxamide triazole derivatives as antimycobacterial agents. RSC Advances 2022, 12, 22385–22401.
  20. Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Kalaga Mahalakshmi Naidu, Banoth Karan Kumar, Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandra Sekhar*, “Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl) -quinoxalin-2-yl)- naphthalen-1-ol analogues.” Toxicology in Vitro 2022, 82, 105370.
  21. Adinarayana Nandikolla, Srinivasarao Singireddi, Karan Kumar Banoth, Sankaranarayanan Murugesan, Himanshu Aggarwal, Rafael Balana-Fouce, Melcon-Fernandez Estela, Kondapalli Venkata Gowri Chandra Sekhar*, “Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agents.” Future Medicinal Chemistry 2022, 14 (12), 867-880.
  22. Faheem, Sanchita, D., Samridhi, J., M. Abirami, Karan Kumar, B., Donatella, T., Nicoletta, B., Rafael B. F., Chandra Sekhar, K.V.G., Murugesan, S., Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: An overview. European Journal of Medicinal Chemistry 2022, 4, 100031
  23. Yogesh, M, K., Surendar, C., Anjani, U. W., Karan Kumar, B., Murali Krishna Kumar M., Murugesan, S., Chandra Sekhar, K.V.G.,*Design, Synthesis and Anti-mycobacterial Evaluation of Imidazo-[1,2-a]-pyridine Analogues. RSC Medicinal Chemistry. 2022, 13, 327-342.
  24. Surendar, C., Sravani, P., Adinarayana, N., Tarun Kumar, P., Karan Kumar, B., Murugesan, S., Balaram, G., Chandra Sekhar, K.V.G.*Design, Synthesis and SAR Studies of Novel Spirochromanone hydrochloride Analogues as Anticancer Agents. Future Medicinal Chemistry, 2022, 22 (5), 325-342.
  25. Archana, B., N.V.M. Rao, B., Raghurami Reddy, B., Suraj, T.G., Subhendu, M., Wesley Roy, B., Sumanth Kumar V., Krishna Satya Alapati, Chandra Sekhar, K.V.G., Kavitha, N., Chandrasekhar, A., Susanta, Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders. Bioorganic & Medicinal Chemistry Letters, 2022, 55, 128448.
  26. Karan Kumar, B., Faheem., Rafael B. F., Estela M. F., Yolanda, Rosa M. R., Adinarayana, N., Chandra Sekhar, K.V.G., Satheesh Varma, V., Murugesan, S.Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents. Journal of Biomolecular Structure and Dynamics 2022, 40 (23), 12592-12607.   
  27. Karan Kumar, B., Faheem,Chandra Sekhar, K.V.G. Rupal O., Vijay Kumar P., Aravinda Pai, Murugesan, S., Pharmacophore based virtual screening, molecular docking, molecular dynamics and MMGBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Journal of Biomolecular Structure and Dynamics, 2022, 40(3), 1363-1386.
  28. Nandikolla, A., Srinivasarao, S., Kumar, B.K., Murugesan, S., Aggarwal, H., Balaña-Fouce, R., Melcón-Fernandez, E., Pérez-Pertejo, Y., Chandra Sekhar, K.V.G. * Novel phenanthridine amide analogs as potential anti-leishmanial agents: In vitro and in silico insights. Bioorganic Chemistry, 2021, 117, 105414.
  29. , Karan Kumar, B., Chandra Sekhar, K.V.G., Subhash Chander, Selvaraj, K., Murugesan, S. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Expert Opinion in Drug Discovery, 2021, 16(10), 1119-114.
  30. Ravi Kiran P., Punna Rao, R., Chandra Sekhar, K.V.G. * Liquid chromatography‑tandem mass spectrometric method for trace quantification of ethyl methanesulfonate: a genotoxic impurity in dapoxetine hydrochloride. Future Journal of Pharmaceutical Sciences, 2021, 7, 191.
  31. Shivani, M., Adinarayana, N., Murugesan, S., Chandra Sekhar, K.V.G.*1,8-Naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities. Future Medicinal Chemistry, 2021, 13(18), 1591-1618.
  32. Yogesh, M, K., Shivani, M., Murugesan, S., Chandra Sekhar, K.V.G.* Oxindole and its derivatives: A review on recent progress in biological activities. Biomedicine & Pharmacotherapy 2021, 141, 111842.
  33. Surendar, C., Sravani, P., Adinarayana, N., Tarun Kumar, P., Karan Kumar, B., Murugesan, S., Balaram, G., Chandra Sekhar, K.V.G.*Design, synthesis and biological evaluation of 7–(5–((substituted – amino)-methyl)-thiophen–2–yl)-spiro-[chroman–2,4′–piperidin]–4–one hydrochloride analogues as anticancer agents. Bioorganic Chemistry, 2021, 112, 104865.
  34. Adinarayana, N., Srinivasarao, S., Yogesh, M.K., Karan Kumar, B., Murugesan, S., Gauri, S., Rui M., Scott, G. F., Chandra Sekhar, K.V.G.*Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis. Toxicology In Vitro, 2021, 74, 105137.
  35. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G,Subhash, C., Selvaraj K, Murugesan, S.Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies. RSC Advances, 2021, 11, 12254–12287.
  36. Ravi Kiran P, Punna Rao R, Chandra Sekhar, K.V.G.*Selective and Sensitive UHPLC Method for the Trace Analysis of Formaldehyde in Drug Substance Using Fused-core Column Technology and Detailed Pre-column Derivatization study. Current Pharmaceutical Analysis, 2021, 17, 201-209.
  37. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G,Selvaraj K, Joazaizulfazli J, Rafael B, Murugesan, S. Recent update on the anti-infective potential of β-carboline analogs. Mini-Reviews in Medicinal Chemistry 2021, 21, 398 – 425.
  38. Adinarayana, N., Srinivasarao, S., Karan Kumar, B., Murugesan, S., Himanshu A., Louise, L.M., Terry, K.S., Chandra Sekhar, K.V.G.*Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues. RSC Advances, 2020, 10, 38328-38343.
  39. Suresh, A., Srinivasarao, S., Yogesh, M. K., Shashidhar, N., Murugesan, S., Chandra Sekhar, K.V.G.*Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective. RSC Advances, 2020, 10, 37098-37115.
  40. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G., Selvaraj, K., Joazaizulfazli, J., Rafael, B. F., Babu, L.T., Murugesan, S. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorganic Chemistry,2020, 104, 104269.
  41. Karan Kumar, B., Faheem, Chandra Sekhar, K.V.G,Adinarayana, N., Murugesan, S. Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update. Heliyon, 2020, 6, e04916.
  42. Srinivasarao, S., Adinarayana, N., Suresh, A., Agnieszka, E., Agnieszka, G.,Balaram, G., Karankumar, B., Murugesan, S., Sravani, P., Himanshu A., Chandra Sekhar, K.V.G.* Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents. Bioorganic Chemistry, 2020, 100, 103955.
  43. Srinivasarao, S., Adinarayana, N., Suresh, A., Kevin Van C, Linda De V, Davie C.,Balaram, G., Himanshu A., Murugesan, S., Chandra Sekhar, K.V.G.* Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents. RSC Advances, 2020, 10, 12272-12288.
  44. Srinivasarao, S., Adinarayana, N., Shashidhar, N., Tsz, T.Y., Sravani, P., Balaram, G., Murugesan, S., Naresh, K., Chandra Sekhar, K.V.G.*Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent Quorum Sensing in Pseudomonas aeruginosa. RSC Advances, 2019, 9, 29273-29292.
  45. Surendar, C., Srinivasarao, S., Santosh, P.K.R., Prakruti, T., Yamini, B., Chandan, K., Krishnan, R., Balaram, G., Chandra Sekhar, K.V.G.*Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents. Bioorganic & Medicinal Chemistry Letters, 2019, 29, 2551-2558.
  46. Suresh, N., Surendar, C., Suresh, A., Sridhar, G., Mallika, A., Debanjan, B., Nishant, J., Chandra Sekhar, K.V.G.*Design, Synthesis, and Biological Evaluation of 2-(4-Aminophenyl) benzothiazole Analogues as Antiproliferative Agents, Journal of Heterocyclic Chemistry, 2019, 56, 520-532.
  47. Arun kumar, T., Ratnakaram V. N., Srinivasu, N., Yamini, B., Balaram, G., Chandra Sekhar, K.V.G.* Design, synthesis and anti-tumour activity of new pyrimidine-pyrrole appended triazoles. Toxicology In Vitro, 2019, 60, 87–96.
  48. Mahalakshmi Naidu, K., Rudresh Naik, G., Chandra Sekhar, K.V.G.*Design, synthesis and biological evaluation of 5-(2-(4-(substitutedbenzo[d]isoxazol-3-yl)piperazin-1-yl)acetyl)indolin-2-one and 5-(2-(4-substituted piperazin-1-yl)acetyl)indolin-2-one analogues as novel anti-tubercular agents. Arabian Journal of Chemistry, 2019, 12, 2418-2429.
  49. Nagesh, H.N., Srinivasarao, S., Suresh, A., Nizalapur, S., Murugesan, S., Kanneboina, K., Kumar, N., Chandra Sekhar, K.V.G.*Sulfur-Assisted Deprotection of Methylene Nitrile Group: One-Pot Synthesis of 4-Substituted-2H-1,2,3-triazoles Chemistry Select, 2018, 3, 7565-7571.
  50. Chander, S., Ashok, P., Reguera, R., Perez, M., Andres, R., Rafael, B., Chandra Sekhar, K.V.G.* Murugesan, S. Synthesis and activity of benzopiperidine, benzopyridine and phenyl piperazine based compounds against Leishmania infantum. Experimental Parasitology, 2018, 189, 49-60.
  51. Srinivasarao, S., Nizalapur, S., Yu T T., Wenholz, D.S., Trivedi, P., Ghosh, B., Rangan, K., Kumar, N., Chandra Sekhar, K.V.G.*Design, Synthesis and Biological Evaluation of Triazole-Containing 2-Phenylindole and Salicylic Acid as Quorum Sensing Inhibitors against Pseudomonas aeruginosa, Chemistry Select, 2018, 3, 9170-9180.
  52. Suresh N., Suresh A., Suresh Y., Manikapal, B., Mallika, A., Chandra Sekhar, K.V.G.*Anti-proliferative activity, molecular modeling studies and interaction with calf thymus DNA of novel ciprofloxacin analogues. Journal of Chemical Sciences 2018, 130, 121.
  53. Suresh, A., Srinivasarao, S., Agnieszka, Ewa, Mallika, A., Lherbet, C, ChandraSekhar, K.V.G.* Design, synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors. Chemical Biology & Drug Design 2017, 91, 1078-1086.
  54. Suresh, N, Chitti S, Suresh, A, Bhattacharjee D, Rao BB, Jain N, Alvala M, Chandra Sekhar, K.V.G.*Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry Letters, 2017, 27, 3794-3801.
  55. Lindemann, M., Deuther-Conrad, W., Moldovan, R., Brust, P., Wenzel, B., Chandra Sekhar, K.V.G. Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter? Bioorganic & Medicinal Chemistry, 2017,25, 5107-5113. 
  56. Suresh, A., Mahalakshmi Naidu K., Srinivasarao, S., Agnieszka,N., Ewa, AK., Misra, S., Murugesan, S., Chander, S., Krishnan, R.,  Chandra Sekhar, K.V.G.* Identification and development of pyrazolo[4,3-c]-pyridine carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. New Journal of Chemistry, 2017, 41, 347-357.
  57. Mahalakshmi Naidu K., Srinivasarao, S., Agnieszka,N., Ewa, A-K., Chandra Sekhar, K.V.G. *Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives. Bioorganic & Medicinal Chemistry Letters, 2016, 26, 2245-2250. 
  58. Suresh, N., Surendar, C., Bhaskara Rao, B., Mallika, A., Nishant J., Chandra Sekhar, K. V. G.* Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.European Journal of Medicinal Chemistry, 2016, 114, 220-231.
  59. Suresh, A., Suresh, N., Misra, S., Krishna Kumar, M.M., Chandra Sekhar, K.V.G.*Design, Synthesis and Biological Evaluation of New Substituted Sulfonamide Tetrazole Derivatives as Antitubercular Agents. Chemistry Select, 2016, 1, 1705-1710.  
  60. Nagesh, H.N., Suresh, A., Reddy, M.N., Suresh, N., Subbalakshmi, J., Chandra Sekhar, K.V.G.*Multicomponent cascade reaction: dual role of copper in the synthesis of 1,2,3-triazole tethered benzimidazo[1,2-a]quinoline and their photophysical studies. RSC Advances, 2016, 6, 15884-15894.
  61. Goh, W., Gardner, C. R., Chandra Sekhar, K.V.G.,Biswas, N. N., Shashidhar, N., Rice, S.C., Willcox, M., Black, D. S., Kumar, N., Synthesis, quorum sensing inhibition and docking studies of 1,5-dihydropyrrol-2-ones. Bioorganic & Medicinal Chemistry, 2015, 23, 7366-7377.
  62. Mahalakshmi Naidu, K., Nagesh, H.N., Singh, M., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.*Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine  as potent Mycobacterium tuberculosis H37Rv inhibitors. European Journal of Medicinal Chemistry, 2015, 92, 415-426.
  63. Nagesh, H.N., Suresh, N., Bhanu Prakash, G.V.S., Gupta, S., Rao, J.V., Chandra Sekhar, K.V.G.* Design, synthesis and biological evaluation of novel phenanthridinyl piperazine triazoles via click chemistry as anticancer agents. Medicinal Chemistry Research 2015, 24, 523-532.
  64. Mahalakshmi Naidu, K., Suresh, A., Subbalakshmi, J., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.* Raghavaiah, P. Design, synthesis and antimycobacterial activity of various 3-(4-substituted sulfonylpiperazin-1-yl)benzo[d]isoxazole derivatives. European Journal of Medicinal Chemistry, 2014, 87, 71-78. 
  65. Nagesh, H.N., Suresh, A., Sairam, S.D.S.S., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.*Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues. European Journal of Medicinal Chemistry, 2014, 84, 605-613.
  66. Nagesh, H.N., Suresh, N., Mahalakshmi Naidu, K., Arun, B., Sridevi, J.P., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.* Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. European Journal of Medicinal Chemistry, 2014, 74, 333-339.
  67. Suresh, N., Nagesh, H.N., Renuka, J., Rajput, V., Sharma, R., Khan, I.A., Chandra Sekhar, K.V.G.* Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl) piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. European Journal of Medicinal Chemistry, 2014, 71, 324-332.
  68. Suresh, N., Nagesh, H.N., Anil Kumar, Shirazi, A.N., Parang, K., Chandra Sekhar, K.V.G.* Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines. Bioorganic & Medicinal Chemistry Letters, 2013, 23 (23), 6292-6295.
  69. Nagesh, H.N., Mahalakshmi Naidu, K., Harika Rao, D., Sridevi, J.P., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.* Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1yl) phenanthridine analogues as antimycobacterial agents. Bioorganic & Medicinal Chemistry Letters, 2013, 23 (24), 6805-6810.
  70. Chandra Sekhar, K.V.G.,* Rao V.S., Conrad W. D., Nagesh, H. N., Sreedhar Kumar, V., Divya Sridhar., Brust P., Murali Krishna M., Synthesis, Preliminary in vitro and in vivo pharmacological evaluation of4-{4-[2-(4-(2-substitutedquinoxalin-3-yl)piperazin-1-yl]ethyl) phenyl}thiazoles as atypical antipsychotic agents. Medicinal Chemistry Research 2013, 22 (4), 1660-1673.
  71. Chandra Sekhar, K.V.G.,* V.S., Tara Sasank, T. V. N. V., Nagesh, H.N., Suresh, N, Mahalakshmi Naidu, K., Suresh, A., Synthesis of 3,5-diarylisoxazoles under solvent-free conditions using iodobenzene diacetate. Chinese Chemical Letters, 2013, 24 (12), 1045 -1048.
  72. Chandra Sekhar, K.V.G.,* Vyas, D. R. K., H N Nagesh, Rao. V.S., Pharmacophore Hypothesis for Atypical Antipsychotics. Bulletin of Korean Chemical Society, 2012, 33 (9), 2930-2936. 
  73. Chandra Sekhar, K.V.G.,* Rao V.S., Kumar, D., Synthesis of Triazolo Quinoxalines as Antitubercular Agents.  Korean Chem. Soc. 2011, 32 (8), 2657-2660.
  74. Chandra Sekhar, K.V.G.,* Rao V.S., Conrad W. D., Satish Reddy A., Brust P., Murali Krishna M. Design, Synthesis and Preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(Substituted thiazolyl)phenylethyl] piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents, Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, 26 (4), 561-568. 
  75. Chandra Sekhar, K.V.G.,* Rao V.S., Satish Reddy, A., Sunandini, R., Kumar Satuluri, V.S.A., Solvent Free Microwave Accelerated Synthesis of Heterocyclic Thiazolidin-4-ones as Antimicrobial and Antifungal Agents. Bulletin of Korean Chemical Society 2010, 31 (5), 1219-1222.
  76. Chandra Sekhar, K.V.G.,* Rao V.S., Murali Krishna Kumar M., Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents. Journal of Enzyme Inhibition & Medicinal Chemistry, 2009, 24(3), 871-875.
  77. Chandra Sekhar, K.V.G.,* Rao V.S., Ravi Kumar Vyas, D., Murali Krishna Kumar M., Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents. Bioorganic & Medicinal Chemistry Letters, 2008, 18, 6054-6057.
  78. Rao, V.S., Chandra Sekhar K.V.G.,* Iodobenzene diacetate mediated solid-state synthesis of Heterocyclyl 1,3,4-oxadiazoles. Synthetic Communications, 2004, Vol.34 (12): 2153-2157.
  79. Kumar, D., Chandra Sekhar, K.V.G., Dhillon, H., Rao, V.S., Varma, R.S., An expeditious synthesis of 1-aryl-4-methyl-1,2,4-triazolo [4,3-a] quinoxalines under solvent-free conditions using iodobenzene diacetate. Green Chemistry, 2004, Vol. 3: 156-157. 
  80. Sriram, D., Rao, V.S., Chandra Sekhar, K.V.G., Yogeeswari, P. Progress in the Research of Artemisinin and its analogues as antimalarials: An Update, Natural Product Research, 2004, Vol.18 (6): 503-527.
  81. Rashmi P., Shaw A.K., Bhaduri A.P., Chandra Sekhar K. V. G., Anil S., Kishore K. S., Vineeta C., Ranjana S., Brahm S. S., Shalini A., Sudhir S., Higher Acyclic Nitrogen containing Deoxy sugar derivatives: A new lead in the generation of antimycobacterial chemotherapeutics. Bioorganic & Medicinal Chemistry, 2002, Vol 10 (6): 1695-1702. 

Conference Articles

  1. Karankumar, Faheem, S. Murugesan, and K. V. G. Chandra Sekhar. Preliminary investigation of drug repurposing as a direction towards anti-Leishmanial drug discovery, International Conference on Drug Discovery (ICDD2020), BITS-Hyderabad, 29thFebruary-2nd March 2020.
  2. Adinarayana, S. Srinivarao, N. Sridhar, S. Murugesan, and K. V. G. Chandra Sekhar. Design, synthesis and biological evaluation of 2-aminobenzimidazoles as Quorum Sensing inhibitors in Pseudomonas aeruginosa.26th Indian Society for Chemists and Biologists Conference jointly organized with 5th Nirma Institute of Pharmacy International Conference, Ahmadabad, 22nd-24th January 2020.
  3. Karankumar, Faheem, G. Surajpyarelal, S. Murugesan, and K. V. G. Chandra Sekhar. In-silico target identification study of novel anti-leishmanial β-carbolineagents. 26th Indian Society for Chemists and Biologists Conference jointly organized with 5th Nirma Institute of Pharmacy International Conference, Ahmadabad, 22nd-24th January 2020.
  4. Faheem, G. Surajpyarelal, B. Karankumar, S. Murugesan, and K. V. G. Chandra Sekhar. In-silico target identification study of novel anti-leishmanial agents. 26thIndian Society for Chemists and Biologists Conference jointly organized with 5th Nirma Institute of Pharmacy International Conference, Ahmadabad, 22nd-24th January 2020.
  5. K. V. G. Chandra Sekhar, S. Srinivasarao, S. Murugesan, and Naresh Kumar. Nitrogen based heterocycles as bacterial Quorum Sensing inhibitors in Pseudomonas aeruginosa. National Conference on New Frontiers in Chemistry - From Fundamentals to Applications (NFCFA2019), BITS, Goa, 20th-22ndDecember 2019. (Invited talk)
  6. Adinarayana, S. Srinivarao, S. Murugesan, and K. V. G. Chandra Sekhar. 5,6-Dimethyl-2-aminobenzimidazoles as bacterial Quorum Sensing inhibitors in Pseudomonas aeruginosa. National Conference on New Frontiers in Chemistry - From Fundamentals to Applications (NFCFA2019), BITS, Goa, 20th-22ndDecember 2019.
  7. Yogesh, C. Surendar, and K. V. G. Chandra Sekhar. 2-(3,4-dimethoxyphenyl)-6(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents. National Conference on New Frontiers in Chemistry - From Fundamentals to Applications (NFCFA2019), BITS, Goa, 20th-22ndDecember 2019.
  8. Adinarayana, S. Srinivarao, H. N. Nagesh, S. Murugesan, and K. V. G. Chandra Sekhar. Deprotection of Methylene Nitrile Using Elemental Sulfur: Novel Strategy in Preparation of 1,2,3-triazoles. National Symposium on Convergence of Chemistry & Materials (CCM), BITS-Pilani Hyderabad campus, Hyderabad, 17-18thDecember 2019.
  9. Srinivasarao, G. Balaram, S. Murugesan and K.V.G. Chandra Sekhar. Design and synthesis of novel 1,2,3-triazole based quorum sensing inhibitors using molecular hybridization approach against Pseudomonas aeruginosa.20th Tetrahedron International Symposium - Bangkok, Thailand, 17-21st June 2019.
  10. K. V.G. Chandra Sekhar,S. Srinivas Rao, and S. Murugesan. Design, Synthesis and Biological Evaluation of triazole containing Salicylic acid as Quorum Sensing Inhibitors against P.aeruginosa. 6th International Conference on Chemistry – Our Health, Our Future, organised by Indian Council of Chemists at Paris, France, June 06-08th, 2019. (Invited talk).
  11. Adinarayana, S. Murugesan and K.V.G. Chandra Sekhar, 3,4-Dihydroisoquinoline benzylidenes and 3,4-dihydroquinoline phenyl acetamides as potent Leishmanial inhibitors. 24th CRSI National Symposium in Chemistry, organized by CLRI and IIT Madras at Chennai, February 8-10th, 2019.
  12. Adinarayana, S. Srinivas Rao, H. N. Nagesh, S. Murugesan and K.V.G. Chandra Sekhar, One-Pot Synthesis of 4-Substituted-2H-1,2,3-triazoles by Deprotection of Methylene Nitrile using elemental sulfur. Drug Discovery in India 2019 -   Breakthrough Research in Medicinal Chemistry, organized by Selectbio Sciences India Pvt. Ltd., Mumbai, January 17-18th, 2019.
  13. Srinivas Rao, A. Suresh and K.V.G. Chandra Sekhar, N. Adinarayana, H. N. Nagesh, S. Murugesan and K.V.G. Chandra Sekhar, Seeking potential Quorum Sensing Inhibitors against Pseudomonas aeruginosa: Design, Synthesis and QSI activity of various triazoles. Drug Discovery in India 2019 -   Breakthrough Research in Medicinal Chemistry, organized by Selectbio Sciences India Pvt. Ltd., Mumbai, January 17-18th, 2019.
  14. Rishi,A. Suresh and K.V.G. Chandra Sekhar, Design and synthesis of 1,2,3-triazolyl sulfonyl analogues as anti-tubercular agents. 24th ISCB International Conference organized by Manipal University, Jaipur, January 11-13th, 2018.
  15. Srinivas Rao, A. Suresh and K.V.G. Chandra Sekhar, Design and synthesis of 1,2,3-triazolyl 9H-fluorenone analogues as anti-tubercular agents. National Symposium on Emerging Trends and Innovations in Pharmaceutical Science (ETIPS-2017) in chemistry, organized by JNTU Hyderabad, October 12-13, 2017. (Won the best paper award in oral section).
  16. Srinivas Rao, A. Suresh and K.V.G. Chandra Sekhar, Design and synthesis of 1,2,3-triazolyl 9H-fluorenone analogues as anti-tubercular agents. National Symposium on Convergence of Chemistry & Materials (CCM-2017) in chemistry, organized by BITS-Pilani, Hyderabad campus, December 21-22, 2017.
  17. Surendar, A. Suresh and K.V.G. Chandra Sekhar, Design and Synthesis of Indole, Oxindole and Isoxazole Derivatives as Quorum Sensing Inhibitors against P.aeruginosa. National Symposium on Convergence of Chemistry & Materials (CCM-2017) in chemistry, organized by BITS-Pilani, Hyderabad campus, December 21-22, 2017.
  18. Ravikiran, R. Punna Rao, B. Mayank, K.V.G. Chandra Sekhar, Analysis of formaldehyde – a human carcinogen in drug substance using ultra-high performance liquid chromatograph. National Symposium on Convergence of Chemistry & Materials (CCM-2017) in chemistry, organized by BITS-Pilani, Hyderabad campus, December 21-22, 2017.
  19. Srinivas Rao, A. Suresh, K. Mahalakshmi Naidu, Napiórkowska Agnieszka, Augustynowicz-Kopec Ewa, Sankaranarayanan Murugesan, Subhash Chander,Rangan Krishnan and K.V.G. Chandra Sekhar, Identification and development of 1,2,3-triazole derivatives of fused pyrazole-dihydropyridine as Mycobacterium tuberculosis Pantothenate synthetase inhibitors. 21st National Symposium in Chemistry, organized by CRSI at Indian Institute of Chemical Technology, Hyderabad, July 13-16, 2017.
  20. K. V.G. Chandra Sekhar,S. Srinivas Rao, K. Mahalakshmi Naidu, Shashidhar Nizalapur, Naresh Kumar, Design and Synthesis of Indole, Oxindole and Isoxazole Derivatives as Quorum Sensing Inhibitors against P.aeruginosa.5th International Conference on Current Concepts in Chemistry, organised by Indian Council of Chemists at Bali, Indonesia, June 07-09th, 2017. (Invited talk).
  21. K. V.G. Chandra Sekhar,Nitrogen based Heterocycles as anti-tubercular agents, National Conference on “Organic Chemistry in Sustainable Development: Recent Advances and Future Challenges (OCSD-2016) organized by Chemistry department, BITS Pilani, August 29-30, 2016.  (Invited talk).
  22. Surendar, A. Suresh and K. V. G. Chandra Sekhar, Design and synthesis of novel fluconazole triazole analogues as anticancer agents. National Conference on “Organic Chemistry in Sustainable Development: Recent Advances and Future Challenges (OCSD-2016) organized by Chemistry department, BITS Pilani, August 29-30, 2016.
  23. Srinivas Rao, K. Mahalakshmi Naidu, A. Suresh, K.V.G. Chandra Sekhar. Synthesis and biological activity of 6-(piperazin-1-yl)phenanthridine sulphonamide derivatives as potent anti-tubercular agents. International Symposium on Bioorganic Chemistry (ISBOC-10), Indian Institute of Science Education and Research, Pune, January 11-15th, 2015.
  24. Suresh, K.Mahalakshmi Naidu, S. Srinivas Rao, K.V.G.Chandra Sekhar. Synthesis and characterization of new tetrazole derivatives as anti-tubercular agents. International Symposium on Bioorganic Chemistry(ISBOC-10), Indian Institute of Science Education and Research, Pune, January 11-15th, 2015.
  25. Suresh, A. Kumar, K. Parang,M. Alvala, K.V.G. ChandraSekhar. Synthesis and anticancer evaluation of novel ciprofloxacin analogues. International Conference on Innovations in Chemical Research and Applied Chemical Sciences at Smt. Chandibai Himathmal Mansukhani College, Ulhasnagar-3, Mumbai, January 12-13th, 2015. (Won the best paper award in poster section).
  26. Mahalakshmi Naidu, H.N.  Nagesh, S. Srinivasarao, A. Suresh, N.Suresh, D. Sriram, K.V.G. Chandra Sekhar,  Design, synthesis and biological evaluation of novel Phenanthridine amide analogues as potent anti-tubercularagents. 13th Eurasia Conference on Chemical Sciences at Indian Institute of Science, Bangalore, India, December 14 - 18th 2014.
  27. N. Nagesh, A. Suresh, D. Sriram, P. Yogeeswari, K.V.G. Chandra Sekhar. A new hybrid approach for design, synthesis and evaluation of substituted phenethylthiazole derivatives as antitubercular agents. 15thTetrahedron Symposium - Asian Edition on Challenges in Bioorganic and Organic Medicinal Chemistry organised by Elsevier at Singapore Expo, Singapore, October 28 -31st, 2014.
  28. K. V.G. Chandra Sekhar, A. Suresh, H.N.Nagesh, N.Suresh, K.Mahalakshmi Naidu, D.Sriram, P.Yogeeswari. Design, Synthesis and anti-tubercular activity of various Phenanthridine analogues. 3rd International Conference on chemistry for sustainable development: Indian perspective, organised by Indian Council of Chemists at Dubai, United Arab Emirates, June 10-14th, 2014.
  29. N.Nagesh, K.Mahalakshmi Naidu, A. Suresh, J.Subbalakshimi, D.Sriram,  P.Yogeeswari, K.V.G. Chandra Sekhar. Design, synthesis and anti-tubercular evaluation of novel benzo[d]isoxazole hybrid analogues. International conference on drugs for the Future: Infectious Diseases, Antimicrobial Drug Discovery: Challenges and perspectives DFID-2014, NIPER, Hyderabad, March 27-28th, 2014.
  30. Mahalakshmi Naidu, A. Suresh, N.Suresh, H.N.Nagesh, K.V.G. Chandra Sekhar. Design, synthesis and in vitro antifungal evaluation of novel ciprofloxacin derivatives. 5thNational seminar on Bioinformatics, Sri Venkateshwara Institute of Medical Sciences, Tirupati, February 14-15th , 2014. (Won the best paper award in poster section).
  31. Mahalakshmi Naidu, H.N.Nagesh, N.Suresh, A. Suresh, K.V.G. Chandra Sekhar, Synthesis and evaluation of phenanthridine analogues as anti-tubercular agents. 16thCRSI Symposium in Chemistry, IIT Bombay, February 7 -9th, 2014.
  32. Suresh, H.N.Nagesh, N.Suresh, K.Mahalakshmi Naidu, D.Sriram, P.Yogeeswari, K.V.G.Chandra Sekhar. Synthesis and anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. International conference on Chemical Biology, Disease mechanisms and Therapeutics (IICB-2014), Indian Institute of Chemical Technology, Hyderabad,  February 6-8th, 2014.
  33. Suresh, H.N.Nagesh, K.Mahalaxmi Naidu, A. Suresh, K.V.G. Chandra Sekhar, K. Parang, Design and synthesis of 1-cyclopropyl-6-fluoro-4-oxo-7-{4-substituted piperazin-1-yl}-1, 4-dihydro quinoline-3-carboxylic acid derivatives asAntiproliferative agents. National Poster- II Symposium on Advances in Organic / Medicinal Chemistry (AOMC-2013), Krishna University, Vijayawada, December 21st, 2013.
  34. Suresh, H.N.Nagesh, K.Mahalaxmi Naidu, Inshad Ali Khan, K.V.G. Chandra Sekhar, Design and synthesis of 1-cyclopropyl-6-fluoro-4-oxo-7-{4-substituted piperazin-1-yl}-1, 4-dihydro quinoline-3-carboxylic acid derivatives as Anti-tubercular agents, 2nd UK-India MedChem Congress, IICT Hyderabad, March 22-23rd, 2013.
  35. N. Nagesh, K. Mahalakshmi Naidu, N. Suresh, K.V.G. Chandra Sekhar, Design and synthesis of novel phenanthridine derivatives as anticancer agents, 19thISCB International Conference (ISCBC – 2013), Mohanlal Sukhadia University Udaipur, March 2-5th, 2013.
  36. Mahalakshmi Naidu, H.N. Nagesh, N.Suresh, K.V.G. Chandra Sekhar, Synthesis Of Benzisoxazolylpiperazines as dopamine D2 antagonists, CTDDR 2013 : 5thInternational Conference on Drug Development and Orphan/Neglected Diseases, CDRI Lucknow, February 26-28th, 2013.
  37. Suresh, H.N.Nagesh, K.Mahalaxmi Naidu, K.V.G. Chandra Sekhar, Design and synthesis of 1, 3-disubstituted 5-(2-(4-substituted piperazine-1-yl) acetyl) indoline-2-one derivatives as anti-cancer agents, 15thCRSI National Symposium in Chemistry, Banaras Hindu University – Varanasi, February 1-3rd, 2013. 
  38. Suresh, H.N.Nagesh, K.Mahalakshmi Naidu, K.V.G. Chandra Sekhar, Design and Synthesis of 1-cyclopropyl-6-fluoro-4-oxo-7-{4-substituted piperazin-1-yl}-1,4-dihydro quinoline-3-carboxylic acid derivatives as anti-tumor agents, 6thMidyear CRSI Symposium in Chemistry, CDRI Lucknow, July 21-22nd, 2012.
  39. N. Nagesh, N.Suresh, K. Mahalakshmi Naidu, V.S. Rao, K.V.G. Chandra Sekhar, Synthesis of Phenanthridinyl piperazines as novel Dopamine D2 antagonists. 14thCRSI National Symposium on Chemistry, CSIR-NIIST, Thiruvananthapuram, February 3-5th, 2012.
  40. K V G Chandra Sekhar, V S Rao, T V N V Tara Sasank, V Sreedhar Kumar, An Expeditious Synthesis of 3,5-Diarylisoxazoles under solvent-free conditions using Iodobenzene diacetate. 13thCRSI National Symposium on Chemistry, NISERKIIT University, Bhubaneshwar, February 4-6th, 2011.
  41. K V G Chandra Sekhar, V S Rao, V Sreedhar Kumar, Design, Synthesis and Pharmacological Evaluation of substituted quinoxalines as Atypical Antipsychotics. 62ndIndian Pharmacutical Congress, Manipal, December 17-19th, 2010, p.B239.
  42. V Sreedhar, V S Rao, W Deuther-Conrad, P Brust, K V G Chandra Sekhar, Design, Synthesis and Preliminary in vitro and in vivo Pharmacological Evaluation of quinoxalinylthiazoles as Atypical Antipsychotic Agents, 5th Midyear CRSI Symposium in chemistry, Trivendrum, July 23-24th, 2010.
  43. K V G Chandra Sekhar, V S Rao, Winnie Deuther-Conrad, Peter Brust, Design, Synthesis and Preliminary in vitro and in vivo Pharmacological Evaluation of 2-{4-[4-(substitutedthiazolyl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as Atypical Antipsychotic Agents. 12th CRSI National Symposium in Chemistry, Indian Institute of Chemical Technology, Hyderabad, India, February 4-7th, 2010.
  44. K. V.G. Chandra Sekhar, V. S. Rao, M. Murali Krishna, R. Mahesh, Synthesis of N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as novel D2 Antagonists: International conference on the interface of chemistry – biology in Biomedical Research, BITS, Pilani, February 22-24th, 2008, p212.
  45. K. V.G. Chandra Sekhar, V.S. Rao and D. Ravi Kumar Vyas, Pharmacophore Hypothesis for Atypical Antipsychotics: International conference on the interface of chemistry – biology in Biomedical Research, BITS, Pilani, February 22-24th, 2008, p202.
  46. K. V. G. Chandra Sekhar, V. S. Rao, Anisha Thomas, A. Satish Reddy, R. Sunandini, V.S.A. Kumar Satuluri, Solvent Free Microwave Assisted Synthesis of 3-(2-methylquinoxalin-3-yl)-2-(substitutedphenyl)thiazolidin-4-ones: International conference on the interface of chemistry – biology in Biomedical Research, BITS, Pilani, February 22-24th, 2008, p125.
  47. Satish, A., K V G Chandra Sekhar, A.Ashok Kumar, V S Rao, Process development of chloroethyl phenylthiazole derivatives – intermediates of novel potential atypical antipsychotics agents: National Symposium on Challenges In Drug Discovery Research: Networking Oppurtunities Between Academia & Industries, BITS, Pilani. April 3-4th, 2006, p 44.
  48. Ashok Kumar, V S Rao, K V G Chandra Sekhar, Vipul Jain. A Cost-effective synthesis of 9-Fluorenone oxime using conventional and microwave approaches: National Symposium on Challenges In Drug Discovery Research: Networking Oppurtunities Between Academia & Industries, BITS, Pilani. April 3-4th, 2006, p 46.
  49. V. S.Rao, K.V.G.Chandra Sekhar, Divya Sridhar and Dalip Kumar, Microwave Assisted Synthesis of Isonicotinoyl Hydrazones. International Symposium on Recent Advances In Drug Design & Delivary Systems, BITS, Pilani, February 26-27th, 2005, p38-39.
  50. V. S.Rao, K.V.G.Chandra Sekhar, A.Ashok Kumar and Dalip Kumar, Synthesis of 1-aryl-4-methyl-1,2,4-triazolo[4,3-a]quinoxalines as Antitubercular Agents: International Symposium on Recent Advances In Drug Design & Delivary Systems, BITS, Pilani, February 26-27th, 2005, p33-34.
  51. K. V.G. Chandra Sekhar, V.S. Rao, Harmeet Dhillon, A. Ashok kumar, Iodobenzene diacetate mediated synthesis of Triazolo Quinoxalines: National Conference for Pharmacy Students, Current Research in Academic Institutions, Shri Vishnu College of Pharmacy, Bhimavaram, March, 7-8th, 2003, p1.

Keep Exploring

Faculty
Events
News